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SignalingSteroid hormone receptors (SHRs) are notorious intracellular travellers, transiting among different cellular
compartments as they mature, are subjected to regulation and exert their biological functions. Under-
standing the processes governing the intracellular trafﬁc of SHRs is important, since their unbalanced or
erroneous localization could lead to the development of diseases. In this review, we not only explore the
functions of the heat-shock protein 90 (Hsp90) molecular chaperone machine for the intracellular transport
of SHRs, but also for the regulation of their nuclear mobility, for their recycling and for the regulation of their
transcriptional output.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Steroid hormone receptors (SHRs) are shuttling proteins, which
continuously undergo nuclear import and export. Depending on their
type and the presence of ligand, they show different subcellular
localizations. Whereas both unliganded and liganded estrogen (ER)
and progesterone receptors (PR) are predominantly nuclear [1-3], the
mineralocorticoid receptor (MR) is partially cytoplasmic and nuclear
without ligand, and nuclear in the liganded form, and unliganded
glucocorticoid (GR) and androgen receptors (AR) are mostly located
in the cytoplasm and completely translocate to the nucleus only after
binding hormone [4-7]. This diversity is most likely the result of a
dissimilar import/export balance [8]. Several scenarios could explain
these differences in intracellular compartmentalization. When nucle-
ar import is limited or impaired, the SHRs get mainly exported, which
results in a full cytoplasmic localization. This could also happen if the
export rate is stimulated. Alternatively, if the export is less efﬁcient
than the import, the receptor accumulates in the nucleus.
Nuclear localization is essential for SHRs to transactivate their
target genes, but the same receptors also possess non-genomic
functions in the cytoplasm. Hence, nucleocytoplasmic shuttling is a
mechanism that could contribute to regulate and to integrate nuclear
transcription with signalling actions in the cytoplasm [9, 10]. SHRs are
not alone in this trafﬁc. They are escorted on their tour by a variety of
molecular chaperones, which regulate their functions in both cellular
compartments. The main partners on this journey seem to be thell rights reserved.heat-shock protein 70 (Hsp70) and Hsp90 molecular chaperones and
their co-chaperones. This review will explore this aspect of the life of
SHRs.
2. Assembly to prepare the departure
Several SHRs, notably GR, MR and AR bind hormone only
efﬁciently as a complex with molecular chaperones and co-chaper-
ones, including notably Hsp90, Hsp70, Hsp organizing protein (Hop),
Hsp90-binding co-chaperone p23 and a J domain-containing protein
such as Hsp40 [11-14]. The SHR–Hsp90 association is essential for SHR
function, since the chaperone maintains its “client” proteins in a
folded and hormone-responsive state [14]. Hsp90 and Hsp70 interact
with co-chaperones containing tetratricopeptide repeat (TPR)
domains through a short C-terminal sequence (EEVD). TPR domains
consist of three or more TPR motifs that are highly degenerate repeats
of 34 amino acids [15]. The Hsp90/Hsp70-TPR interaction is highly
conserved and TPR proteins (TPRp) are widely distributed in the
animal and plant kingdoms [16]. FKBP52, FKBP51 and cyclophilin 40
(Cyp40), Hop, the serine-threonine protein phosphatase 5 (PP5), and
Tpr2 are some of the TPR proteins that are able to associate with
Hsp90 [17-21]. Moreover, these co-chaperones can also be found in
SHR–Hsp90 complexes [16, 22-24]. FKBP52 and FKBP51, and Cyp40
are also known as the large immunophilins since, in addition to the
TPR domain, they contain a peptidyl prolyl isomerase (PPIase) domain
that can bind immunosuppressive drugs such as FK506 and
cyclosporin A, respectively. Our journey into the life of SHRs starts
when Hsp70 transfers SHRs such as GR to Hsp90 via Hop, which binds
both chaperones through two separate TPR domains [25] (Fig. 1). The
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stabilized by p23, which is an Hsp90 co-chaperone generally involved
in the stabilization Hsp90-client complexes, and this constitutes an
essential step in their maturation [26,27] (Fig. 1). Similarly to p23,
another Hsp90 co-chaperone, Aha1, boosts the activation of GR by the
Hsp90 machinery in yeast and in mammalian cells [28]. In the
presence of ATP, the afﬁnity of Hsp90 for Hop decreases, which allows
the entrance of the TPR proteins, FKBP52, FKBP51, Cyp40 or PP5. All
these TPRp bind and compete for the same TPR binding domain of
Hsp90 [29] (Fig. 1). Finally, this assembly and maturation process
produces a GR–Hsp90 complex with high hormone binding afﬁnity
and responsiveness. As alluded to above, different SHRs have a
somewhat different Hsp90 dependence, either for hormone binding
or response.
3. The cytoplasmic journey to the nucleus
3.1. Steroid receptors, NLSs and import receptors
After binding the ligand, SHRs move to the nucleus to function as
transcription factors. Like other nuclear proteins, the SHRs need
transport signals and transport receptors to reach the nucleus. All
SHRs comprise a modular and conserved structure with an N-
terminal transactivation domain, a DNA-binding domain (DBD), a
short hinge region and a hormone-binding domain (HBD) that also
has transactivation function. In the case of GR, a basic nuclear
localization signal (NLS), NL1, overlaps the DBD-hinge region and a
second NLS activity, NL2, is located within the HBD [4]. NL1 is
equivalent to the basic bipartite signal found in nucleoplasmin, and it
is also found in the same region of AR, ER and PR [4,30-32]. Some NL2
import activity similar to that of GR has also been detected in the
HBDs of AR, ER and PR [4,31,33]. The nuclear import of GR is mediated
by the interaction of these NLSs with proteins that are transport
factors, called importins. Importin-αUimportin-β1 heterodimers, as
well as importin-7, interact with NL1 [34]. On the other hand, NL2
can be recognized by importin-7 and -8, but not by importin-α [34]
(Fig. 1). It is worth noting that GR-importin interactions can be
ligand-dependent or independent [4,34].
3.2. Microtubule-associated nuclear localization of SHRs
It has been proposed that the nuclear localization of SHRs is also
controlled by the Hsp90 machinery through the recruitment of the
large immunophilins FKBP52, FKBP51, or Cyp40 to the SHR–Hsp90
complex in their last step of maturation [25,35,20]. This mode of
movement requires the interaction with microtubule-associated
molecular motors [36] (Fig. 1). Some TPRp such as FKBP52, Cyp40
and PP5 directly interact with the motor protein dynein (Fig. 1),
either through their PPIase domain in the case of the two afore-
mentioned immunophilins or the related phosphatase domain for
PP5 [37]. The interaction of Hsp90–TPRp complexes with dynein thus
represents a link between GR and the cytoskeleton and appears to be
essential for rapid nuclear localization [38]. The treatment with the
Hsp90 inhibitor geldanamycin (GA) slows the rate of nuclear
localization of ligand-bound GR. It has been shown that FKBP52
stimulates the transcriptional activity of GR [49], AR [40] and PR [41],
but not MR [42], while FKBP51 either has no effect or even inhibits
[39,42]. Interestingly, the PPIase domain of FKBP51 is unable toFig. 1. Assembly, hormone binding and import pathways to the nucleus of SHRs. (1) The SHR
bound form of Hsp90 allows the displacement of Hop by immunophilins (Imm) and conform
stabilizes the complex, which now possesses high hormone binding afﬁnity. (2) Unligand
nucleus by several import pathways. The dynein-based nuclear localization involving the
microtubules (MTs) towards their minus end. The hormone bound SHR–Hsp90 complex
importins to be translocated into the nucleus (6). SHRs complexed with the Hsp90 machine
importin transporters by multiple contacts between receptor, Hsp90 and importin β1, and su
dynein; Nup62: nucleoporin 62.interact with dynein. Without hormone, FKBP51 is the major
immunophilin in GR–Hsp90 complexes (Fig. 1), whereas after
hormone treatment, FKBP52 rapidly replaces FKBP51 such that
these complexes are now able to translocate to the nucleus with an
accelerated rate [43] (Fig. 1). As a consequence, the relative
abundance of these immunophilins might regulate GR localization
and action. Interestingly, some new world primates such as squirrel
monkeys have high levels of several steroid hormones [44,45]. They
display altered relative levels of immunophilins, with high levels of
FKBP51 and low levels of FKBP52 potentially being responsible for
the apparent glucocorticoid [46] and androgen resistance [47]. At the
same time, steroids are themselves capable of regulating the
expression of immunophilins. FKBP52 is induced by estrogens [48],
while FKBP51 can be induced by glucocorticoids, androgens and
progestins [49-51]. Altogether these ﬁndings point to the importance
of the Hsp90 chaperone machine, and especially its FKBP compo-
nents, in the regulation of SHR action, possibly by regulating the
microtubule-associated nuclear localization.
Surprisingly, in an unrelated set of experiments, Chambraud and
collaborators [52] have found that FKBP52 binds tubulin and prevents
its polymerization with corresponding effects on neuronal cells. Since
this FKBP52 activity involves the TPR domain, it remains to be seen
whether Hsp90-binding through this domain diverts FKBP52 away
from this activity and promotes its PPIase-dependent association with
dynein. It is conceivable that the formation of such alternate
complexes could be regulated in a tissue-speciﬁc fashion.
3.3. Several coexisting mechanisms for nuclear import of SHRs
Despite the observed microtubule-associated nuclear localization
of SHRs, GR and PR can reach the nucleus in cells whose cytoskeleton
has been disrupted. This movement is believed to be driven by the
standard nuclear localization mechanism and in an Hsp90-indepen-
dent fashion [53-55]. Recently, an interesting link between NLS/
importin-dependence and the ability to bind the dynein light chain
has been established for the rabies virus P-protein, both features
acting synergistically to facilitate nuclear import [56]. PTHrP and p53
are additional examples of proteins imported by both mechanisms
[57-59]. In addition to binding Hsp90, FKBP52 is able to interact with
GR directly [60]. This raises the theoretical possibility that FKBP52
could act as a GR transporter by itself (Fig. 1). Whether and when this
happens remains unclear in view of the fact that the association of
FKBP52 with nuclear pores [61] and its stimulatory effects for steroid
receptor function [39] are Hsp90-dependent. Nevertheless, it appears
that SHRs may be imported by several mechanisms including
conventional NLS-mediated nuclear targeting by importins, microtu-
bule-associated nuclear localization and even diffusion (Fig. 1). The
presence of alternative pathways for nuclear import might facilitate
the rapid and efﬁcient translocation of proteins under different
physiological conditions where importin-dependent and/or cytoskel-
eton-dependent pathways may be compromised. Recently, the
potential relationship between GR–Hsp90–TPRp complexes and the
nuclear import/export machinery could also be predicted with an in
silico approach based on protein-protein interaction (PPI) databases
generated from large-scale experiments (for example, yeast-two
hybrid assays, afﬁnity puriﬁcation, protein chips, etc.) [61]. This
interactome network was created by integrating data from several PPI
repositories into predictive interologmaps, where a pair of interactingchaperoned by Hsp70 and Hsp40 binds Hsp90 via Hop (and its TPR domains). The ATP-
ational changes that the SHR need to bind hormone efﬁciently. The arrival of p23 ﬁnally
ed GR preferentially binds the Imm FKBP51. Liganded SHRs can be transported to the
entire Hsp90 machine (3) or just FKBP52 (4). Dynein mediates the transport along
is unstable and highly dynamic (5). Liganded and unliganded SHRs can bind several
(and possibly also transported by MTs as indicated by the question mark) can reach the
bsequently arrive at the nuclear pore complex to bind Nup62 (7). Dyt: dynamitin; Dyn:
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interacting orthologous proteins in another species. The predicted
interactions of GR and Hsp90 with Importin-β1 and with the integral
nuclear pore glycoprotein Nup62, which also interacts with Hsp70,
p23, and the TPRp FKBP52 and PP5, could be conﬁrmed experimen-
tally. Interestingly, Nup62 and GR are capable of interacting more
efﬁciently when functional Hsp90 is present in the system [61]. The
Hsp90 machine might help GR to bind to the nuclear pore complex,
thus facilitating its transport into the nucleus (Fig. 1). It is conceivable
that the NLS/importin-dependent mode of nuclear localization can
also engage the microtubule-dependent transport system, and vice
versa, but this remains to be clariﬁed. Hence, for SHRs, the Hsp90
machine might be involved in different import pathways (Fig. 1),
regulating, facilitating or coordinating the pathways that these
receptors use to translocate to the nucleus under different physio-
logical conditions or in different cell types (for example, in neurons,
which need a rapid and long range transport along axons). The
dynamic/unstable nature of SHR–Hsp90 complexes might help SHRs
to use Hsp90 as a pivot to move between the different nuclear import
pathways that are available (Fig. 1).
3.4. Hsp90–SHR complexes—disrupt or do not disrupt?
Despite all of the data discussed above, it is still not clear whether
hormone-bound SHRs translocate through the nuclear pores before or
after dissociation from the Hsp90 complex. The most widely accepted
model involved the disruption of Hsp90–SHR complexes following
hormone binding. GR or PR-Hsp90 complexes stabilized with
molybdate, a compound which stabilizes Hsp90–SHR complexes in
an ATP-bound state [26], cannot be transported into the nucleus
[62,63] even in the presence of hormone. This could imply that the
disruption of SHR–Hsp90 complexes is necessary to allow nuclear
import. However, taking into account that GR cannot bind importin-α
in the presence of molybdate [64], that molybdate treatment also
induces structural changes in the C-terminal domain of Hsp90, which
might affect its interaction with substrates [65], and that molybdate is
known to be a phosphatase inhibitor, it could be argued that the
effects of molybdate are indirect. Indeed, cross-linked GR-Hsp90
heterocomplexes are able to translocate into the nucleus in digitonin-
permeabilized cells in the presence of glucocorticoid [61], arguing
very strongly that GR-Hsp90 complexes can cross the nuclear pore as
a multicomponent complex (Fig. 1). If this is indeed the case, one
would have to hypothesize that SHR–Hsp90 complexes would
eventually disintegrate within the nucleus, several minutes after
ligand binding initially started the whole process in the cytoplasm.
What might drive this dissociation in the nucleus remains
unexplained.
4. Nucleus, should I stay or should I go?
4.1. Nuclear export of SHRs
Why and how do SHRs move to the nucleus? Why and how do
they stay in it? Nuclear localization is necessary for SHRs to
transactivate their target genes. Moreover, nuclear retention and
nuclear export could regulate the relative contributions of SHRs to
non-genomic functions in the cytoplasm and to transcription in the
nucleus. Thus, nucleocytoplasmic shuttling may be a regulated
mechanism for integrating transcription with signalling events in
the cytoplasm [9,10,66]. For instance, an unbalanced cytoplasmic
localization of α isoform of ER (ERα) enhances the non-genomic
effects of ERα, which has been proposed to contribute to tumorigen-
esis as well as anti-estrogen resistance of breast cancer cells [67,68].
Thus, we need to consider how SHRs can be exported from the
nucleus. The best-known nuclear export mechanism uses the export
receptor exportin-1 (XPO1), which binds proteins containing aleucine-rich nuclear export sequence (NES) to promote protein export
from the nucleus. The treatment of cells with leptomycin B (LMB), a
potent and speciﬁc inhibitor of XPO1-dependent nuclear export, does
indeed inhibit the nuclear export of some SHRs [64,69-71]. It is
conceivable that SHRs interact directly with XPO1, either using their
own NES or via adapter proteins such as members of the 14-3-3
family or p160 co-activators that contain a NES [72-74]. Interestingly,
TPR proteins and 14-3-3 proteins share similar structural and
functional properties [75]. 14-3-3 proteins were also proposed to
possess chaperone activity [76] and to interact with GR thereby
favouring its cytoplasmic localization through the 14-3-3 export
signal [73]. Nevertheless, for some SHRs speciﬁc NESs have been
identiﬁed. A region in the LBD of AR allows its nuclear export and is
dominant over the reported AR NLS in the absence of ligand. This
ligand-regulated NES was shown also to be present in MR and ERα
[71]. Later, Lombardi and colleagues [77] found that a leucine-rich
sequence of ERα contains a functional NES that lies in the same region
previously pinpointed by Saporita et al. [71]. This sequence is
sensitive to LMB treatment and allows a hormone-bound ERα to be
exported from the nuclei through the XPO1 pathway, and again,
homologous sequences of this NES were found in ERβ, PR, AR, MR and
GR [77]. Despite the presence of a NES in SHRs, the nuclear export
mechanism for some of them is controversial. LMB was observed to
impair the export of GR in COS-7 cells but to promote the nuclear
accumulation of the B isoform of PR in T47D cells [64,78]. In other
studies, the nuclear export of PR was shown to be XPO1-independent
and to involve its NLS [79,80]. In yet other contradictory reports, the
export of GR was not affected by LMB, neither in COS-7 cells [81] nor
in BHK cells, where it was demonstrated to be regulated by
calreticulin, a protein normally located in the lumen of the
endoplasmic reticulum [82] (Fig. 2).
4.2. Hsp90 and SHRs nuclear export
The role of chaperones and of the Hsp90 machine in the nuclear
export of SHRs is still poorly understood. The same in silico analysis
discussed above [61] also predicted a relationship of the GR–Hsp90–
TPRp complex with the nuclear export machinery in an interaction
network that interconnects the complex with several nucleoporins,
XPO1 and Ran proteins. Experimentally, the nuclear accumulation of
liganded and unliganded GR is severely impaired upon overexpres-
sion of the PP5 TPR domain, a phenomenon that is overcome when
cells are treated with LMB (P. C. Echeverria and M. D. Galigniana,
unpublished results). This suggests the existence of a connection
between GR (and the Hsp90–TPRp complex) and XPO1, dependent on
some TPR protein and/or on the integrity of the complex.
4.3. Chaperones and the intranuclear mobility of SHRs
The historical view of Hsp90 just accompanying SHRs during their
ﬁrst steps of maturation is gradually shifting to the idea that the
Hsp90 complex is a full-time and multifunctional partner of these
receptors. Fluorescence recovery after photobleaching (FRAP) studies
have shown that several nuclear proteins including SHRs are highly
mobile [83,84]. Elbi and colleagues [85] showed that multiple
chaperone proteins are required for maximal nuclear mobility of
liganded/unliganded GR and PR, and that these proteins are the same
ﬁve chaperones and co-chaperones needed for the assembly of SHR
complexes in vitro. The function of this mobility is still not well
understood. It has been observed that there is a rapid exchange of
GFP-tagged GR on a tandem array of GR target sites [83]. It was
proposed that this rapid exchange could allow SHRs to sample
changes in hormone concentrations or that it is a consequence of
changes in hormone levels [83,84,86]. Freeman and Yamamoto [86]
showed evidence that Hsp90 and p23 promote the disassembly of
transcriptional regulatory complexes assembled by GR (Fig. 2). Using
Fig. 2. Intranuclear dynamics of SHRs. Hsp90 and p23 promote a dynamic interaction of SHRs with chromatin (1 and 2). SHRs undergo rapid exchange on chromatin, lose hormone
and regain steroid binding capacity through the Hsp90 chaperone cycle (3), allowing them to bind chromatin again. Unliganded receptors could get degraded (4) or exported
through the nuclear pores (5), either by XPO1 or calreticulin-dependent systems. In addition, Hsp90 acts as a nuclear retention factor impeding SHR export 6).
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and Hsp90 localize to glucocorticoid response elements (GREs) in a
hormone-dependent manner. Furthermore, targeting a Gal4 DBD-p23
fusion protein next to a GRE diminishes the transcriptional activation
by GR, consistent with the idea that p23 might be involved in
removing GR from chromatin. A different set of experiments led to the
seemingly contradictory conclusions that nuclear Hsp90 is necessary
for the nuclear retention of SHRs, since treatment of cells with Hsp90
inhibitors accelerated the nuclear export of GR and PR after
withdrawal of ligands [87,88].
Whereas GR, p23 and Hsp90 localize to GR response elements in a
hormone-dependent manner, Hsp70 is not recruited [86]. In contrast,
in the case of ERα cycling at the pS2 promoter, Hsp70 (but possibly
not Hsp90) appears during the ERα clearance phase, which reinforces
the idea of the role of molecular chaperone machines in the
intranuclear dynamics of SHRs [89]. When GR is released from
chromatin in its unliganded form, it is ﬁrst located in a subnuclear
compartment where it can either be exported or regain the capacity to
bind to chromatin upon rebinding hormone [90], a process that once
more is Hsp90-dependent [91]. The proposed roles of chaperones in
intranuclear SHRs dynamics are summarized in Fig. 2.4.4. How do SHRs, deep in the nucleus, sense ﬂuctuating hormone levels
in the blood?
In humans, cortisol concentrations are not only inﬂuenced by
circadian ﬂuctuations and by food consumption or exercise, but by a
pulsatile mode of release [92,93]. Circulating estradiol levels also
ﬂuctuate across the reproductive cycle [94]. SHRs should be able to
respond to these pulsatile or ﬂuctuating serum levels of hormones
with sensitive mechanisms, including within the nucleus. SHR–Hsp90
assembly and nuclear import/disassembly and export pathways must
be ﬁnely tuned to these hormone oscillations. Molecular chaperones
have been proposed to be key factors in regulating a continuous
dissociation and recycling of SHRs form their target genes, allowing a
rapidly adapting response to systemic hormone changes [95]. As
mentioned above, molecular chaperones appear indeed to be involved
in disassembling and recycling of SHRs from their response elements.
In a very recent paper, Hager and colleagues [96] demonstrated that
the pulsatile release of glucocorticoids is accompanied by a pulsed
expression of GR-regulated genes. This pulsatile expression is driven
by a rapid and continuous GR exchange at GREs, and by GR recycling
through the Hsp90 chaperone machine to regain ligand binding
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chromatin (see also Fig. 2). As soon as hormone levels decrease, the
pool of unliganded GR increases, GR molecules detach from target
GREs and transcriptional stimulation subsides. At least for GR, a
transcriptional activity coupled to ﬂuctuating hormone levels could be
observed, whereas other steroid hormones show different patterns of
ﬂuctuation, which seem to correlate with different intranuclear
recycling behaviour of their corresponding receptors [89,94,97].
5. Future approaches
This review highlights the strong relationship between SHRs and
molecular chaperones along their cellular lifetime. The best charac-
terized processes are the assembly, maturation and nuclear localiza-
tion, while their intranuclear mobility, receptor-chromatin dynamics
and nuclear export are signiﬁcantly less well understood. Much of the
knowledge has been gained with the GR and then extrapolated to
other SHRs. It is still unclear how chaperones could participate in the
regulation of so many different steps of SHR action while being part of
similar complexes. Since these complexes are present in different
environments, it might be there where they encounter other key
regulators. To gain a better understanding, systems biology might
provide a better methodology. Rather than analyzing SHRs and their
chaperone companions as isolated entities, it may be more appropri-
ate to view them as a part of a system of protein complexes. Yeast-
based reporter assays like the one published by Balsiger and Cox [98]
might help to achieve a functional characterization of a wide variety of
SHR-chaperone interactions by combining SHR and co-chaperone
expression plasmids, reporter plasmids, and ligand in large-scale
studies. Similarly, using a genome-wide set of gene deletions in yeast,Fig. 3. A predicted interaction map of the Hsp90/70 machines and SHRs based on combine
machines (query proteins) was collected from POINT [106], a database for the prediction o
proteins in different organisms). The PPI map is also dissected according to the annotated s
than one compartment. Gene ontology information was retrieved from the database DAV
Cytoscape [108]. Proteins that are involved in intracellular/nucleocytoplasmic shuttling acca systematic identiﬁcation of modulators of the aryl hydrocarbon
receptor (AhR) was possible [99]. With these data, a PPI network
could be generated, which describes AhR signalling.
In the last decade, the application of high-throughput technologies
such as large-scale yeast two-hybrid analyses has generated a vast
amount of data [100,101] and has allowed the construction of several
PPI databases [102]. The use of these databases represents a very
powerful approach for generating hypotheses for empirical studies of
protein networks. As an example, we mined these databases for the
relationship between the whole set of human SHRs and the Hsp90/
Hsp70-co-chaperone machines and obtained the PPI network shown
in Fig. 3. Remarkably, at the intersection of the predicted interactomes
of the Hsp70/90machines and the SHRs, 20% of the genes have a gene
ontology function annotated to be in intracellular transport and/or
nucleocytoplasmic shuttling (Fig. 3, proteins highlighted in red). A
signiﬁcant part of the combined interactome is related to protein
transport, which emphasizes the importance of trafﬁc in SHR biology
and the chaperone partnership.
The fact that all SHRs are nucleocytoplasmic shuttling proteins
seriously complicates the analysis of the role of other factors such as
the Hsp90 molecular chaperone machine. While analyzing, for
instance, the nuclear localization of a particular protein, the
concomitant nuclear export of the very same protein could confound
the situation. New technologies and experimental cell systems are
necessary to efﬁciently separate both compartments in order to start
experiments with SHRs and/or modulators fully restricted to one
compartment. An interesting tool to accomplish this is the anchor-
away technique recently developed in the Laemmli laboratory [103].
With this system, it is possible to sequester a protein (the target) in
one speciﬁc compartment (cytoplasm or nucleus) by anchoring it tod interactomes. Interactome data for each protein of the SHR family and the Hsp90/70
f human PPI which employs the concept of interologs (orthologous pairs of interacting
ubcellular localization of each component. Note that some proteins can belong to more
ID [107], and interaction maps were visualized and manipulated using the software
ording to their gene ontology annotation are highlighted in red.
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compartment, thereby depleting the target protein from the other
compartment. This technique is based on the rapamycin-induced
heterodimerization of the human FKBP12 with the FRB domain of
human mTOR. To exclusively compartmentalize a given SHR in the
cytoplasm or the nucleus, it would be necessary to develop
corresponding systems of heterodimerization of an SHR with an
anchor. This should be inducible with a small molecule as well as
reversible. Unfortunately, the FKBP12-rapamycin system does not
appear to be the best candidate since rapamycin cannot be efﬁciently
removed [103].
A correct and efﬁcient intracellular localization of SHRs plays an
essential role in maintaining major functions in the life of a cell and in
the physiology of vertebrates. In this regard, there are interesting
studies carried out by Kanwal and colleagues [104] who are
attempting to manipulate protein shuttling with the ultimate goal
of treating diseases by correcting protein mislocalization. They have
developed protein constructs, which localize in a particular cellular
compartment in response to external ligands on the one hand, and
heterologous proteins with altered NLS/NES strengths that could be
used to rectify the effect of a mislocalized endogenous protein
involved in disease [105], on the other hand.
More work needs to be done to complete the whole picture for all
SHRs in order to understand the common and the different features
that they have in their biology, a picture, indeed a movie, where the
chaperone machines will be the main actors.
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